Definition
Cognitive dysfunction in human immunodeficiency virus (HIV)-infected patients is common and can be a difficult diagnosis for the treating physician in the face of multiple potential causes. Cognitive dysfunction persists in up to 50 % of HIV-infected patients in the post-highly active antiretroviral therapy (post-HAART) era, with milder forms predominating (Cysique et al. 2004; Cohen and Gongvatana 2010). The differential diagnoses are divided into those relevant to virally suppressed patients and those that are not, with HIV-associated neurocognitive disorder (HAND) common to both groups.
In patients who are virally suppressed, the diagnoses more commonly encountered, apart from HAND, are substance abuse, psychiatric illness, and hepatitis C, both through its direct effects on cognition and through hepatic encephalopathy. The clinical significance of ageing and neurodegenerative diseases such as Alzheimer’s and vascular cognitive impairment is not presently clear though the...
References
Ances BM, Vaida F, Yeh MJ, Liang CL, Buxton RB, Letendre S, McCutchen JA, Ellis RJ. HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging. J Infect Dis. 2010;201:336–40.
Ances BM, Benzinger TL, Christensen JJ, Thomas J, Venkat R, Teshome M, Aldea P, Fagan AM, Holtzman D, Morris JC, Clifford DB. 11C-PiB Imaging of human immunodeficiency virus–associated neurocognitive disorder. Arch Neurol. 2012;69(1):72–7.
Asch SM, Kilbourne AM, Gifford AL, Burnam MA, Turner B, Shapiro MF, Bozzette SA, HCSUS Consortium. Underdiagnosis of depression in HIV: who are we missing? J Gen Intern Med. 2003;18(6):450.
Becker JT, Kingsley L, Mullen J, Cohen B, Martin E, Miller EN, Ragin A, Sacktor N, Selnes OA, Visscher BR. Vascular risk factors, HIV serostatus and cognitive dysfunction in gay/bisexual men. Neurology. 2009;73(16):1292–9.
Brew BJ. AIDS dementia complex. In: HIV neurology. 1st ed. New York: Oxford University Press; 2001.
Brew BJ, Cysique LA. Alzheimer disease and HIV: a tangled story. Neurology. 2010;75:105–6.
Brew BJ, Crowe SM, Landay A, Cysique LA, Guillemin G. Neurodegeneration and ageing in the HAART era. J Neuroimmune Pharmacol. 2009;4(2):163–74.
Cohen RA, Gongvatana A. The persistence of HIV-associated neurocognitive dysfunction and the effects of comorbidities. Neurology. 2010;75:2052–3.
Currier JS, Lundgren JD, Carr A, Klein D, Sabin CA, Sax PE, Schouten JT, Smieja M. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation. 2008;118:e29–35.
Cysique LA, Maruff P, Brew BJ. Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus–infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J NeuroVirol. 2004;10:350–7.
Fedele F, Bruno N, Mancone M. Cardiovascular risk factors and HIV disease. AIDS Rev. 2011;13(2):119–29.
Foley J, Ettenhofer M, Wright M, Hinkin CH. Emerging issues in the neuropsychology of HIV infection. Curr HIV/AIDS Rep. 2008;5(4):204–11.
Garvey LJ, Pflugrad H, Thiyagarajan A, et al. Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients. Neurology. 2010;74:779.
Gheuens S, Wuthrich C, Koralnik I. Progressive multifocal leukoencephalopathy:why gray and white matter? Annu Rev Pathol Mech Dis. 2013;8:189–215.
Gourevitch MN, Friedland GH. Interactions between methadone and medications used to treat HIV infection: a review. Mt Sinai J Med. 2000;67(5–6):429.
Hinkin CH, Castellon SA, Levine AJ, et al. Neurocognition in individuals co-infected with HIV and hepatitis C. J Addict Dis. 2008;27:11–7.
Hogg RS, Althoff KN, Samji H, Cescon A, Modur S, Buchacz K, Burchell AN, Cohen M, Gebo KA, Gill MJ, Justice A, Kirk G, Klein MB, Korthuis PT, Martin J, Napravnik S, Rourke SB, Sterling TR, Silverberg MJ, Deeks S, Jacobson LP, Bosch RJ, Kitahata MM, Goedert JJ, Moore R, Gange SJ, for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the IeDEA. Increases in life expectancy among treated HIV-positive individuals in the United States and Canada, 2000–2007. IAS 2013 conference poster. http://pag.ias2013.org/Abstracts.aspx?AID=2451. Accessed 15 Oct 2013.
Koralnik IJ. Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name? Ann Neurol. 2006;60(2):162.
Letendre SL, Cherner M, Ellis RJ, et al. The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS. 2005;19 Suppl 3:S72–8.
Margolin A, Avants SK, Warburton LA, Hawkins KA. Factors affecting cognitive functioning in a sample of human immunodeficiency virus-positive injection drugusers. AIDS Patient Care STDS. 2002;16(6):255–67.
Nguyen TP, Soukup VM, Gelman BB. Persistent hijacking of brain proteasomes in HIV-associated dementia. Am J Pathol. 2010;176(2):893–902.
Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P. HIV-1 infection and cognitive impairment in the cART era: a review. AIDS. 2011;25:561–75.
Simioni S, Cavassini M, Annoni JM, Métral M, Iglesias K, Abraham AR, Jilek S, Calmy A, Müller H, Fayet-Mello A, Giacobini E, Hirschel B, Du Pasquier RA. Rivastigmine for HIV-associated neurocognitive disorders. Neurology. 2013;80:553–60.
Spronk DB, van Wel JH, Ramaekers JG, Verkes RJ. Characterizing the cognitive effects of cocaine: a comprehensive review. Neurosci Biobehav Rev. 2013;37(8):1838–59.
Thein H-H, Maruff P, Krahn M, Kaldor JM, Koorey DJ, Brew BJ, Dore GJ. Improved cognitive function, mood, and health-related quality of life in HCV monoinfected and HIV/HCV coinfected individuals with pegylated interferon alfa-2a and ribavirin. HIV Med. 2007;8(8):520–8.
Wilkinson J, Radkowski M, Laskus T. Hepatitis C virus neuroinvasion: identification of infected cells. J Virol. 2009;83:1312–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this entry
Cite this entry
Garber, J.Y., Brew, B.J. (2015). Differential Diagnosis of HIV-Associated Neurocognitive Disorders. In: Hope, T., Stevenson, M., Richman, D. (eds) Encyclopedia of AIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9610-6_215-1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9610-6_215-1
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-9610-6
eBook Packages: Springer Reference MedicineReference Module Medicine